Search

Author/Creator Engebråten, Olav

1. Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model. Issue 1 (December 2016)

Authors:
Kim, Eugene; Tunset, Hanna; Cebulla, Jana; Vettukattil, Riyas; Helgesen, Heidi; Feuerherm, Astrid; Engebråten, Olav; Mælandsmo, Gunhild; Johansen, Berit; Moestue, Siver
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Basal‐like breast cancer engages tumor‐supportive macrophages via secreted factors induced by extracellular S100A4. Issue 9 (9th August 2018)

Authors:
Prasmickaite, Lina; Tenstad, Ellen M.; Pettersen, Solveig; Jabeen, Shakila; Egeland, Eivind V.; Nord, Silje; Pandya, Abhilash; Haugen, Mads H.; Kristensen, Vessela N.; Børresen‐Dale, Anne‐Lise; Engebråten, Olav; Mælandsmo, Gunhild M.
Journal:
Molecular oncology
Issue:
Volume 12:Issue 9(2018)
Page Start:
1540
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. In Vivo 31P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts. Issue 3 (14th February 2014)

Authors:
Esmaeili, Morteza; Moestue, Siver A.; Hamans, Bob C.; Veltien, Andor; Kristian, Alexandr; Engebråten, Olav; Mælandsmo, Gunhild M.; Gribbestad, Ingrid S.; Bathen, Tone F.; Heerschap, Arend
Journal:
Journal of magnetic resonance imaging
Issue:
Volume 41:Issue 3(2015)
Page Start:
601
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗